2. Search Result
Search Result
No matches for "

(S)-Tamsulosin-d3

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

97

Inhibitors & Agonists

1

Biochemical Assay Reagents

2

Peptides

7

Natural
Products

1

Antibodies

4

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-17518A
    (S,S)-Valifenalate

    (S,S)-IR5885; (S,S)-Valiphenal

    		 Fungal Infection
    (S,S)-Valifenalate ((S,S)-IR5885) is an acylamino acid fungicide and is used to control a wide range of fungi belonging to the class of Oomycetes. (S,S)-Valifenalate ((S,S)-IR5885) interferes with the cell-wall synthesis thus affecting the growth stages of the pathogens controlled, both outside (on the spores) or inside the plant (on the mycelium) .
    (<em>S</em>,<em>S</em>)-Valifenalate
  • HY-125845A
    (S,S,S)-AHPC hydrochloride
    1 Publications Verification

    (S,S,S)-VH032-NH2 hydrochloride

    		 Ligands for E3 Ligase Cancer
    (S,S,S)-AHPC hydrochloride is a von Hippel-Lindau (VHL) amino building block. (S,S,S)-AHPC (Compound 27) is a ligand used as a negative control for (S,R,S)-AHPC. (S,R,S)-AHPC is the VH032-based VHL ligand used in the recruitment of the VHL protein .
    (<em>S</em>,<em>S</em>,<em>S</em>)-AHPC hydrochloride
  • HY-123109A
    (S,S,S)-AHPC-Boc

    (S,S,S)-VH032-Boc

    		 Others Cancer
    (S,S,S)-AHPC-Boc is the isomer of (S,R,S)-AHPC-Boc (HY-123109), and can be used as an experimental control. (S,R,S)-AHPC-Boc (VH032-Boc) is a ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC-Boc is used in PROTAC technology .
    (<em>S</em>,<em>S</em>,<em>S</em>)-AHPC-Boc
  • HY-107409B
    (S,S)-GNE 5729

    		Others Others
    (S,S)-GNE 5729 is a (S,S)-enantiomer of GNE 5729 (HY-107409) .
    (<em>S</em>,<em>S</em>)-GNE 5729
  • HY-15344A
    (S,S)-BD-AcAc 2

    (S,S)-Ketone Ester

    		 Others Neurological Disease
    (S,S)-BD-AcAc 2 ((S,S)-Ketone Ester) is a (S,S)-enantiomer of BD-AcAc 2. BD-AcAc 2 elevates the AcAc and acetone levels, thereby produces sustained ketosis and significantly delays central nervous system oxygen toxicity (CNS-OT) seizures .
    (<em>S</em>,<em>S</em>)-BD-AcAc 2
  • HY-78931B
    (S,S,S,S,R)-Boc-Dap-NE

    		Others Cancer
    (S,S,S,S,R)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (<em>S</em>,<em>S</em>,<em>S</em>,<em>S</em>,R)-Boc-Dap-NE
  • HY-W074930
    (S)-Tenofovir

    (S)-GS 1278; (S)-PMPA; (S)-TDF

    		 HIV HBV Infection
    (S)-Tenofovir ((S)-GS 1278) is the less active S-enantiomer of Tenofovir. Tenofovir is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV) .
    (<em>S</em>)-Tenofovir
  • HY-16776A
    (2S,5S)-Censavudine

    (2S,5S)-Festinavir; (2S,5S)-BMS-986001; (2S,5S)-OBP-601

    		 HIV Infection
    (2S,5S)-Censavudine ((2S,5S)-OBP-601) is the (2S,5S)-enantiomer of Censavudine. Censavudine, a nucleoside reverse transcriptase inhibitor, is a potent HIV inhibitor . (2S,5S)-Censavudine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    (2<em>S</em>,5<em>S</em>)-Censavudine
  • HY-105008
    Secoisolariciresinol diglucoside
    4 Publications Verification

    (S,S)-SDG; (S,S)-LGM2605

    		 Others Cardiovascular Disease Neurological Disease Inflammation/Immunology
    Secoisolariciresinol diglucoside ((S,S)-SDG), the main lignan in wholegrain flaxseed, is known for its beneficial effects including anti-inflammatory, antioxidant, anti-mutagenic, anti-microbial, anti-obesity, hypolipidemic, and neuroprotective effects .
    Secoisolariciresinol diglucoside
  • HY-101877
    Statine

    (3S,4S)-Statine; (S,S)-Statine

    		 Others Endocrinology
    Statine is an unusual amino acid that occurs twice in the sequence of pepstatin, a protease inhibitor that is active against pepsin and other acid proteases.
    Statine
  • HY-Y1069
    (S)-Malic acid
    1 Publications Verification

    (S)-Hydroxybutanedioic acid; (S)-E 296
    (S)-Malic acid ((S)-2-Hydroxysuccinic acid) is a dicarboxylic acid in naturally occurring form, contributes to the pleasantly sour taste of fruits and is used as a food additive.
    (<em>S</em>)-Malic acid
  • HY-138506
    DBCO-S-S-acid

    		ADC Linker Cancer
    DBCO-S-S-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-S-S-acid is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
    DBCO-<em>S</em>-<em>S</em>-acid
  • HY-N3045
    (S,S)-Pisatin

    		Others Others
    (S,S)-Pisatin (compound 8) is a dimeric pterocarpan derivative is isolated from the grains of millettia pachyloba .
    (<em>S</em>,<em>S</em>)-Pisatin
  • HY-14855A
    (S)-Tedizolid

    (S)-TR 700; (S)-DA 7157

    		 Bacterial Antibiotic Infection
    (S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.
    (<em>S</em>)-Tedizolid
  • HY-15114
    S 17092

    S 17092-1

    		 Prolyl Endopeptidase (PREP) Neurological Disease
    S 17092 (S 17092-1) is a potent cerebral prolyl-endopeptidase (PEP) inhibitor with an IC50 of 1.2 nM. S 17092 can be used for the research of memory impairment and cognitive disorders associated with cerebral aging .
    <em>S</em> 17092
  • HY-126049
    (S)-Oxiracetam

    (S)-(-)-Oxiracetam; (S)-ISF2522

    		 Apoptosis Neurological Disease
    (S)-oxiracetam (S-ORC) is an inhibitor targeting apoptosis. S-ORC reduces brain infarct size and lessens neurological dysfunction in middle cerebral artery occlusion/reperfusion (MCAO/R) models. S-ORC prevents neuronal apoptosis via activating PI3K/Akt/GSK3β signaling pathway via α7 nAChR after ischemic stroke. S-ORC can prevent neuronal death after ischemic stroke .
    (<em>S</em>)-Oxiracetam
  • HY-116152A
    (S)-Cipepofol

    (S)-Ciprofol; (S)-HSK3486

    		 GABA Receptor Neurological Disease
    (S)-Cipepofol is the isomer of Cipepofol (HY-116152).Cipepofol (HSK3486) is a sleep-promoting active molecule and a gamma-aminobutyric acid (GABA) receptor enhancer .
    (<em>S</em>)-Cipepofol
  • HY-130285
    10(S),17(S)-DiHDHA

    10(S),17(S)-DiHDoHE; PDX

    		 Endogenous Metabolite Inflammation/Immunology
    10(S),17(S)-DiHDHA (also known as neuroprotectin D1 when produced in neuronal tissues) is a DHA-derived dihydroxy fatty acid that exhibits potent protective and anti-inflammatory activities .
    10(<em>S</em>),17(<em>S</em>)-DiHDHA
  • HY-14940A
    (S)-Volinanserin

    (S)-MDL100907; (S)-M 100907

    		 5-HT Receptor Neurological Disease
    (S)-Volinanserin is an isform of Volinanserin (HY-14940). Volinanserin is a potent and selective antagonist of 5-HT2 receptor, with a Ki of 0.36 nM, and shows 300-fold selectivity for 5-HT2 receptor over 5-HT1c, alpha-1 and DA D2 receptors. Volinanserin has antipsychotic activity.
    (<em>S</em>)-Volinanserin
  • HY-14778A
    (S)-Retosiban

    (S)-GSK 221149; (S)-GSK 221149A

    		 Others Neurological Disease Endocrinology
    (S)-Retosiban is the isomer of Retosiban (HY-14778), and can be used as an experimental control. Retosiban (GSK221149A) is a potent and selective oxytocin antagonist with a Ki of 0.65 nM.
    (<em>S</em>)-Retosiban
  • HY-50856A
    Ruxolitinib (S enantiomer)
    4 Publications Verification

    S-Ruxolitinib; S-INCB18424

    		 JAK Cancer
    Ruxolitinib (S enantiomer) (S-Ruxolitinib) is the S-enantiomer of Ruxolitinib (HY-50856). Ruxolitinib (S enantiomer) is an orally active, potent JAK inhibitor .
    Ruxolitinib (<em>S</em> enantiomer)
  • HY-B0006B
    (S)-Carvedilol

    (S)-BM 14190

    		 Adrenergic Receptor Cardiovascular Disease
    (S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX) .
    (<em>S</em>)-Carvedilol
  • HY-B0352A
    (S)-Mirtazapine

    (S)-Org3770; (S)-6-Azamianserin

    		 5-HT Receptor Neurological Disease
    (S)-Mirtazapine ((S)-Org3770) is a S(+)-enantiomer of Mirtazapine with pronociceptive properties in an animal model of acute thermal nociception. (S)-Mirtazapine is a stereoselective 5-HT2 receptor antagonist. (S)-Mirtazapine is metabolized by CYP2D6 and CYP1A2 .
    (<em>S</em>)-Mirtazapine
  • HY-107661A
    S-(+)-Arundic Acid

    (S)ONO-2506; (S)-2-Propyloctanoic acid

    		 Others Others
    S-(+)-Arundic Acid ((S)ONO-2506) is the S-enantiomer of Arundic Acid. Arundic acid is an astrocyte-modulating agent, has the potential for stroke and Alzheimer’s disease research .
    <em>S</em>-(+)-Arundic Acid
  • HY-14147A
    (S)-Renzapride

    (S)-BRL 24924

    		 5-HT Receptor Metabolic Disease
    (S)-Renzapride ((S)-BRL 24924) is the isomer of HY-14147 Renzapride. Renzapride is a 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride also is a 5HT2b and 5HT3 receptor antagonist. Renzapride can be used for constipation predominant irritable bowel syndrome (C-IBS) study .
    (<em>S</em>)-Renzapride
  • HY-78931A
    (R,S,S,R,S)-Boc-Dap-NE

    		Others Cancer
    (R,S,S,R,S)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (R,<em>S</em>,<em>S</em>,R,<em>S</em>)-Boc-Dap-NE
  • HY-78931C
    (S,S,R,S,R)-Boc-Dap-NE

    		Others Cancer
    (S,S,R,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (<em>S</em>,<em>S</em>,R,<em>S</em>,R)-Boc-Dap-NE
  • HY-78931F
    (R,S,S,S,R)-Boc-Dap-NE

    		Others Cancer
    (R,S,S,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (R,<em>S</em>,<em>S</em>,<em>S</em>,R)-Boc-Dap-NE
  • HY-78131A
    (S)-(+)-Ibuprofen

    (S)-Ibuprofen

    		 COX Inflammation/Immunology
    (S)-(+)-Ibuprofen ((S)-Ibuprofen), a S(+)-enantiomer of Ibuprofen, is a potent COX-1 and COX-2 inhibitor with IC50s of 2.1 μM and 1.6 μM, respectively. (S)-(+)-Ibuprofen has analgesic, anti-inflammatory, anticancer and antipyretic effects .
    (<em>S</em>)-(+)-Ibuprofen
  • HY-U00281
    S16961

    S169611

    		 nAChR Neurological Disease
    S16961 is a nicotinic receptor agonist.
    <em>S</em>16961
  • HY-104003
    S 38093

    		Histamine Receptor Neurological Disease Endocrinology
    S 38093 is a brain-penetrant, orally active antagonist of H3 receptor, with Kis of 8.8, 1.44 and 1.2 µM for rat, mouse and human H3 receptors, respectively.
    <em>S</em> 38093
  • HY-106992
    S 3304

    		MMP Cancer
    S 3304 is a novel matrix metalloproteinases (MMP) inhibitor specific for MMP-2 and MMP-9. S 3304 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    <em>S</em> 3304
  • HY-14658A
    (S)-Thalidomide

    (S)-(-)-Thalidomide

    		 Apoptosis Molecular Glues Metabolic Disease Inflammation/Immunology
    (S)-Thalidomide ((S)-(-)-Thalidomide) is the S-enantiomer of Thalidomide. (S)-Thalidomide has immunomodulatory, anti-inflammatory, antiangiogenic and pro-apoptotic effects . (S)-Thalidomide induces teratogenic effects by binding to cereblon (CRBN) .
    (<em>S</em>)-Thalidomide
  • HY-135336A
    (S)-Verapamil hydrochloride

    (S)-(-)-Verapamil hydrochloride

    		 Leukotriene Receptor Calcium Channel Apoptosis Cancer
    (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells .
    (<em>S</em>)-Verapamil hydrochloride
  • HY-10936
    S 18986

    		iGluR Neurological Disease
    S 18986 is a selective, orally active, brain penetrant positive allosteric modulator of AMPA-type receptors. S 18986 shows cognitive enhancing properties in rodents. S 18986 activates the release of noradrenaline and acetylcholine in rat hippocampus and enhances rat memory in object-recognition tests .
    <em>S</em> 18986
  • HY-B1370A
    (S)-Hydroxychloroquine

    (S)-HCQ

    		 Parasite Toll-like Receptor (TLR) SARS-CoV Autophagy Infection
    (S)-Hydroxychloroquine ((S)-HCQ) is the enantiomer of Hydroxychloroquine . Hydroxychloroquine, a synthetic antimalarial agent, inhibits Toll-like receptor 7/9 (TLR7/9) signaling, and shows efficiently inhibits SARS-CoV-2 infection in vitro .
    (<em>S</em>)-Hydroxychloroquine
  • HY-N2037B
    (S)-Higenamine

    (S)-Norcoclaurine

    		 Endogenous Metabolite Others
    (S)-Higenamine ((S)-Norcoclaurine), a S-enantiomer of Higenamine, is the entry compound in benzylisoquinoline alkaloid biosynthesis. (S)-Higenamine is produced by the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) by norcoclaurine synthase (NCS) .
    (<em>S</em>)-Higenamine
  • HY-11053
    S 24795

    		nAChR Neurological Disease
    S 24795 is a partial agonist of α7 nAChR and improves mnemonic function in aged mice for the research of aging-related memory disturbances .
    <em>S</em> 24795
  • HY-107728
    S 25585

    		Neuropeptide Y Receptor Metabolic Disease
    S 25585 is a potent and selective neuropeptide Y (NPY) Y5 receptor antagonist. S 25585 reduces food intake but not through blockade of the NPY Y5 receptor .
    <em>S</em> 25585
  • HY-16657A
    (S,S)-TAPI-1

    		MMP Inflammation/Immunology Cancer
    (S,S)-TAPI-1 is an isomer of TAPI-1. TAPI-1 is a TACE (ADAM17) inhibitor and blocks the shedding of several cell surface proteins. TAPI-1 is also a metalloproteinase (MMP) inhibitor .
    (<em>S</em>,<em>S</em>)-TAPI-1
  • HY-128888A
    (S,S)-GSK321

    		Isocitrate Dehydrogenase (IDH) Cancer
    (S,S)-GSK321 is a (S,S)-enantiomer of GSK321 .
    (<em>S</em>,<em>S</em>)-GSK321
  • HY-141848A
    (S,S)-BMS-984923

    		mGluR Neurological Disease
    (S,S)-BMS-984923 is a less active (S,S)-enantiomer of BMS-984923. (S,S)-BMS-984923 shows an EC50 >1μM for mGluR5 receptor . BMS-984923 is a potent mGluR5 silent allosteric modulator . (S,S)-BMS-984923 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    (<em>S</em>,<em>S</em>)-BMS-984923
  • HY-114072A
    (S,S)-J-113397

    		Opioid Receptor Neurological Disease
    (S,S)-J-113397 is an isomer of J-113397 (HY-114072). J-113397 is an Opioid Receptor antagonist .
    (<em>S</em>,<em>S</em>)-J-113397
  • HY-109854
    (S)-Lisofylline

    (S)-Lisophylline

    		 Others Inflammation/Immunology
    (S)-Lisofylline ((S)-Lisophylline)) is a kind of lisofline (LSF) enantiomer with optical activity. (S)-Lisofylline can interconversion with pentoxifylline .
    (<em>S</em>)-Lisofylline
  • HY-100741A
    (S,R)-S63845

    		Others Cancer
    (S,R)-S63845 is the isomer of S63845 (HY-100741), and can be used as an experimental control. S63845 is a potent and selective myeloid cell leukemia 1 (MCL1) inhibitor with a Kd of 0.19 nM for human MCL1 .
    (<em>S</em>,R)-<em>S</em>63845
  • HY-104003A
    S 38093 hydrochloride

    		Histamine Receptor Neurological Disease
    S 38093 hydrochloride is a brain-penetrant, orally active antagonist of H3 receptor, with Kis of 8.8, 1.44 and 1.2 µM for rat, mouse and human H3 receptors, respectively.
    <em>S</em> 38093 hydrochloride
  • HY-145386
    (S,S)-CPI-1612

    		Others Cancer
    (S,S)-CPI-1612 is the isomer of CPI-1612 (HY-136285), and can be used as an experimental control. CPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC50 of 8.1 nM for EP300 HAT. CPI-1612 has an anticancer activity .
    (<em>S</em>,<em>S</em>)-CPI-1612
  • HY-120928
    S 16474

    		Neurokinin Receptor Neurological Disease Inflammation/Immunology
    S 16474 is a cyclic peptide with antagonistic effects on NK1 and NK2 receptors. S 16474 can be used in the study of neurogenic inflammation .
    <em>S</em> 16474
  • HY-E70236
    CoA-S-S-CoA

    		Endogenous Metabolite Others
    CoA–S-S–CoA is an endogenous metabolite found inP. furiousus. CoA–S-S–CoA is a substrate of NOXA2 .
    CoA-<em>S</em>-<em>S</em>-CoA
  • HY-50687
    (3S,4S)-Tivantinib

    (3S,4S)-ARQ 197; ARQ 198

    		 Others Cancer
    (3S,4S)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (3S,4S)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC) .
    (3<em>S</em>,4<em>S</em>)-Tivantinib

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation: * Country or Region:
* Applicant Name: * Organization Name:
* Department:    
* Email Address: * Product Name:
Cat. No.: * Requested quantity:
* Phone Number:    
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: